Search Within

Roni Shouval

Formats
  1. Meeting Abstract (92)
  2. Journal Article (63)
  3. Review (6)
  4. Editorial (4)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (173)
  2. Center for Hematologic Malignancies (112)
  3. Department of Medicine (112)
  4. Bone Marrow Transplant (105)
  5. CTCR Scholars (88)
  6. Survivorship Research (86)

More Groups

People
  1. Miguel-Angel Perales (101)
  2. Michael Scordo (83)
  3. Gunjan Shah (80)
  4. Maria Palomba (75)
  5. Sean Devlin (65)
  6. Parastoo Dahi (64)

More People

Years
  1. 2025 (22)
  2. 2024 (42)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (65)
  2. Bone Marrow Transplantation (20)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (13)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Elsevier Inc. (27)
  3. Nature Publishing Group (27)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Bridging radiotherapy may decrease inflammation prior to CAR-T cell therapy
    Meeting Abstract

    Patel, R. R.; Tward, A.; Fregonese, B.; Hubbeling, H.; Lapen, K.; Mankuzhy, N. P.; Raj, S. S.; Perales, M. A.; Shouval, R.; Yahalom, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CD19 CAR-T cell therapy is effective in Richter transformation: A multicenter retrospective analysis by the European Research Initiative on chronic lymphocytic leukemia
    Meeting Abstract

    Beyar-Katz, O.; Benjamini, O.; Delgado, J.; Ruella, M.; Ram, R.; Grisariu, S.; Visentin, A.; Vandenberghe, E.; Gentile, M.; Avigdor, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschè‚nes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of immune reconstitution and their clinical significance in aggressive lymphoma treated with CAR-T therapy
    Meeting Abstract

    Luan, D. Y.; Dewolf, S.; Fei, T.; Raj, S. S.; Shah, G. L.; Lareau, C.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Inflammation-based scores predict survival after CD3xCD20 bispecific T cell engagers in R/R LBCL
    Meeting Abstract

    Magno, G.; Rejeski, K.; Rappa, G.; Kupf, S.; Stock, S.; Holzem, A. M. E.; Scholz, J. K.; Wurm-Kuczera, R.; Harlev, S.; Kutsch, N.; more...
    Blood (2024)

    Fulltext@MSK | Save